Pfizer Inc. (PFE) on Decifer

Why it ranks here

• It earns solid returns on the money it puts to work, around 9% and it turns most of its profit into real cash.
• Revenue is not growing right now.
• It keeps a high share of every sale as profit.
• and has the balance sheet to fund its growth.
• It is not watering down its owners with new shares.

The current read

The evidence on PFE lines up on the supportive side: the intelligence feed flags this name as connected to what is moving markets now. The independent signals we track are telling the same story.

Themes

• Healthcare, Biotech & Devices: Pfizer Inc. sits in the large-cap pharma layer of the Healthcare, Biotech & Devices story.

Read the full PFE research brief · See all quality rankings

Intelligence data powered by Decifer. Not financial advice. For informational purposes only.